MARY SCHRIEVER: Open Payments
NPI 1366173114 · LOCKPORT, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$352 in 20 payments from 12 companies in 2025. Trend: 2023 $872 · 2024 $799 · 2025 $352
Food & beverage: $352
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $75 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $50 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $33 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $31 |
| Edwards Lifesciences Corporation | 1 | $29 |
| Lilly USA, LLC | 2 | $27 |
| Corcept Therapeutics | 1 | $21 |
| Verona Pharma, Inc. | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $17 |
Products named: Kerendia, JARDIANCE, CAPLYTA, SAPIEN 3 Ultra RESILIA, Korlym, Ohtuvayre, CAPVAXIVE, Ozempic.
Industry payments across NY — which companies pay providers there.
